TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Knee Injury and Osteoarthritis Outcome Score (KOOS) sport and recreation sub-scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Marx Activity Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 90-day hospitalization for any cause
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Gastric Half-emptying Time (GE T 1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in food intake and appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Response at 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain pressure algometer temporal summation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Anxiety Control Questionnaire (ACQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Activity Social Distancing Intentions - 3 item version (SOC-D)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Absolute and relative change of T cell subsets in the peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Absolute and relative change of B-cell subsets in the peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline in levels of markers of autoimmunity (ANA, cANCA and pANCA) in the serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Differential expression pattern of circRNA/lncRNA/miRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of self-reported postoperative nausea
Endpoint domain: Adverse events/effects
Primary endpoint: muscle spindle-based reflex latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to closed thoracostomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: AUC/MIC of vancomycin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrahepatic total fat and lipid composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HPV vaccine immunogenicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of perineal tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Physician comfort level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants With On-Treatment Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With AEs Led to Withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: 12 Month Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients with at least one flare
Endpoint domain: Adverse events/effects
Primary endpoint: HIV Knowledge Confidence
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Avoiding Risky Sex
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: Avoiding Risky Drug Use
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: HIV Testing Awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk Reduction Skills
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: PI ratio in the little digit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood-plasma Concentration of Piperacillin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Time Curve From Time Zero to 24 Hours (AUC0-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Drug Clearance (CLtotal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy Expenditure by infant metabolic chamber
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Energy expenditure by doubly labeled water
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of efficacy after switching TPO mimetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right sided hemodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Quantitative Myasthenia Gravis (QMG) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Number of Nights of Splint Wear
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Participants With Non-Vertebral Fragility Fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in spatiotemporal gait measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best disease control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Burn wound healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Cortisol Concentration after ACTH Challenge Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in Albumin Corrected Serum Calcium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Knowledge level of kidney recipients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sensibility of the pulps of thumb, index finger, and middle finger
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viral DNA and infectious virus monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change From Baseline in Fraction of Exhaled Nitric Oxide (FeNO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mobility index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mathematics test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: change in VAS pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Visual vertical and visual orientation degrees
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Chemotherapy Toxicities (Grade 3 - 5)
Endpoint domain: Adverse events/effects
Primary endpoint: Tattoo Removal Efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Results of skin test/provocation test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage agreement of Dip HBDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with newly diagnosed cancer
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients enrolled in clinical trials
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients without clinical or radiographic progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal allograft markers of damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Evolving injury in biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Location of infection in head and neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevention of myelotoxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of chemotherapy cycles
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of advanced imaging studies
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in the Community Reintegration of Injured Service Members Computer Adaptive Test (CRIS-CAT)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Gene expression changes in the small airway epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Marijuana Abstinence (2 Weeks or Greater)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Marijuana Abstinence (4 Weeks or Greater)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean pain score (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Durvalumab with Carboplatin/Paclitaxel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of Durvalumab with Carboplatin/Paclitaxel
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of post-spinal anesthesia hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Clinician Administered PTSD Scale for DSM-V (CAPS-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number and severity of events reported
Endpoint domain: Adverse events/effects
Primary endpoint: Cmax during the first and last dosing interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach Cmax (tmax) during the first and last dosing interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCτ on the first and last day of study treatment intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete remission or partial regression to CIN 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Swanson, Nolan, and Pelham, version IV scale (SNAP-IV-C)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: onset time surgical readiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Concentrations of follicular fluid AMH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cumulative continuation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of major structural defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: perioperative and postoperative complication rates
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical Global Impression-Efficacy Index (CGI-EI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cohen's kappa of pathogen isolation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Serum antitoxin IgG concentrations to Clostridium difficile toxins A and B
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety profile in terms of solicited and unsolicited reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Post operative graft function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Melody contour identification test (% correct)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of all-cause death, myocardial infarction, and stroke or systemic embolism
Endpoint domain: Mortality/survival
Primary endpoint: Percent of Time With Sensed Glucose 70-180 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent of Time With Sensed Glucose Less Than 70 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hyperalgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: cell count differences in induced sputum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Metabolic Equivalent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from basal plasma lipopolysaccharide (LPS) at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: MRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline on CLASS assessment tool
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline on Symptoms Checklist 90 Revised
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline on Maslach Burnout Inventory - Education Survey
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Maximum inter-incisal opening (MIO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and intensity of hot flashes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to result relative to conventional microbial culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance compared to conventional culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drop outs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in tumor volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Episodes of nosocomial sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of responders based on AHI reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Response to treatment with candesartan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bilateral knee Range Of Motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Ranibizumab therapies needed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to Loss of Therapeutic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Survival (OS) Rates
Endpoint domain: Mortality/survival
Primary endpoint: Concentration of Certolizumab Pegol (CZP) in Breast Milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Calculated Daily Infant Dose of Certolizumab Pegol (CZP) in Breast Milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Average Daily Infant Dose of Certolizumab Pegol (CZP) Over the Dosing Interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Pattern of bioimpedance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chest Pain Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in headache frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in body composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change in inflammatory markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Diet quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area under ROC curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coefficient of reproducibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of neuralgia
Endpoint domain: Adverse events/effects
Primary endpoint: Biatrial contractility recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in Brain Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Score difference on discomfort visual analogic scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Successful isolation of exosomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgeon satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 3 year biochemical progression free survival (PSA)
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline of Pt CO2 measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline of PaCO2 measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline of alveolar dead space (VD/VT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: amelioration of episodes of autonomic dysreflexia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Investigator Assessment of Spasticity Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Spasticity not Receiving Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spasticity Symptom Assessment Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to fill bony defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Markers of breast cancer progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of Treatment-Associated Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Patients With DLTs
Endpoint domain: Adverse events/effects
Primary endpoint: 6 Month Local In-field Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 6-minute walk test dyspnea levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in 6-minute walk test fatigue levels
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Failure event free survival at 3 years
Endpoint domain: Mortality/survival
Primary endpoint: Amsel criteria laboratory diagnostic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With a Complete Response (CR) + Partial Response (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Efavirenz
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary fluoride excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of minor adverse events (MAEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline to 24 week visit in glomerular filtration rate (GFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change from baseline to 24 week visit in estimated glomerular filtration rate (eGFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change from baseline to 24 week visit in need for dialysis
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean peak intra-tumoral lactate/pyruvate (lac/pyr) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean lactate area under curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean peak conversion of HP 13C pyruvate to lactate (kPL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Urea AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean urea transfer constant (Ktrans)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Patients With Clinical Cure at Test-of-cure Visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of body mass index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of circumference of wrist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of circumference of waist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of dense red blood cells (DRBC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pain Disability Index Score (PDI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Progression of adrenomyeloneuropathy (AMN) as determined by a motor function test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infected pancreatic necrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: QT Interval Corrected for Heart Rate (QTc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in blood levels of SCCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percent days abstinent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of head and neck cancer patients
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients adherent to smoking abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status